Stacey C. Sigmon

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

Michelle R. Lofwall, Sharon Walsh, Edward V. Nunes et al. · JAMA Internal Medicine · 2018 · 249 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact

John R. Brooklyn, Stacey C. Sigmon · Journal of Addiction Medicine · 2017 · 236 citations · Full text

Pharmacy, Health Services Administration, Pain Management +15

Community Reinforcement Therapy for Cocaine-Dependent Outpatients

Stephen T. Higgins, Stacey C. Sigmon, Conrad J. Wong et al. · Archives of General Psychiatry · 2003 · 198 citations

Medicine, Psychiatry, Addiction Counseling +16

Access to Treatment for Opioid Dependence in Rural America

Stacey C. Sigmon · JAMA Psychiatry · 2014 · 177 citations

Nursing, Community Health, Pharmaceutical Policy +14

Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction

Stephen T. Higgins, Sarah H. Heil, Stacey C. Sigmon et al. · JAMA Psychiatry · 2017 · 119 citations

Public Health, Behavioral Sciences, Psychiatry +17